Yong‐Chul Kim

发表

Synthesis and structure-activity relationships of novel indirubin derivatives as potent anti-proliferative agents with CDK2 inhibitory activities.

Woo Keun Song, Sang Kook Lee, W. Song, 2006, Bioorganic & medicinal chemistry.

Acyl‐hydrazide derivatives of a xanthine carboxylic congener (XCC) as selective antagonists at human A2B adenosine receptors

K. Jacobson, Yong‐Chul Kim, J. Linden, 1999 .

MIPs are ancestral ligands for the sex peptide receptor

B. Dickson, Yoshiaki Tanaka, Young-Joon Kim, 2010, Proceedings of the National Academy of Sciences.

Discovery of substituted indole derivatives as allosteric inhibitors of m6A‐RNA methyltransferase, METTL3‐14 complex

Yong‐Chul Kim, M. Jin, Je-Heon Lee, 2022, Drug development research.

Evidence for the recognition of non‐nucleotide antagonists within the transmembrane domains of the human P2Y1 receptor

S. Moro, K. Jacobson, Yong‐Chul Kim, 2002, Drug development research.

ENOblock, a unique small molecule inhibitor of the non-glycolytic functions of enolase, alleviates the symptoms of type 2 diabetes

W. S. Kang, Darren R. Williams, So Hun Kim, 2017, Scientific Reports.

Characterization of LDD-2633 as a Novel RET Kinase Inhibitor with Anti-Tumor Effects in Thyroid Cancer

Jungil Choi, Hyo-Jeong Lee, Yong‐Chul Kim, 2021, Pharmaceuticals.

Discovery of LDD-1075 as a potent FLT3 inhibitor.

Jungil Choi, Hyo-Jeong Lee, Yong‐Chul Kim, 2019, Oncology letters.

Characterization of the Indirubin Derivative LDD970 as a Small Molecule Aurora Kinase A Inhibitor in Human Colorectal Cancer Cells

Hyo-Jeong Lee, Yong‐Chul Kim, Sun-Young Han, 2017, Immune network.

Discovery of indirubin derivatives as new class of DRAK2 inhibitors from high throughput screening.

Joo Yun Lee, Byung Jin Byun, Yong‐Chul Kim, 2016, Bioorganic & medicinal chemistry letters.

5'-OH-5-nitro-Indirubin oxime (AGM130), an Indirubin derivative, induces apoptosis of Imatinib-resistant chronic myeloid leukemia cells.

Yong‐Chul Kim, Min-Jung Lee, Jae-Il Kim, 2013, Leukemia research.

Enhancing effect of indirubin derivatives on 1,25-dihydroxyvitamin D3- and all-trans retinoic acid-induced differentiation of HL-60 leukemia cells.

Si-Wouk Kim, Soo-Jeong Choi, Yong‐Chul Kim, 2006, Bioorganic & medicinal chemistry.

Discovery of indirubin-3'-aminooxy-acetamide derivatives as potent and selective FLT3/D835Y mutant kinase inhibitors for acute myeloid leukemia.

Myung Jin Kim, Yong‐Chul Kim, Je-Heon Lee, 2022, European journal of medicinal chemistry.

5‐Nitro‐5′hydroxy‐indirubin‐3′oxime Is a Novel Inducer of Somatic Cell Transdifferentiation

Darren R. Williams, Yong‐Chul Kim, Young-Jin Hong, 2014, Archiv der Pharmazie.

Actions of a series of PPADS analogs at P2X1 and P2X3 receptors

G. Burnstock, K. Jacobson, Yong‐Chul Kim, 2001, Drug development research.

Crystal structure of Rattus norvegicus Visfatin/PBEF/Nampt in complex with an FK866-based inhibitor

S. Eom, Yong‐Chul Kim, Mun-kyoung Kim, 2009, Molecules and cells.

Total synthesis of 8-oxypseudopalmatine and 8-oxypseudoberberine via ring-closing metathesis

Yong‐Chul Kim, W. Cho, D. B. Khadka, 2009 .

Discovery of orally active indirubin-3'-oxime derivatives as potent type 1 FLT3 inhibitors for acute myeloid leukemia.

Na Yoon Kim, Jungil Choi, Hyo-Jeong Lee, 2020, European journal of medicinal chemistry.

Benzofuroindole Analogues as Potent BKCa Channel Openers

Yong‐Chul Kim, Chul-Seung Park, T. Ha, 2005, Chembiochem : a European journal of chemical biology.

Inhibition of ecto‐apyrase and ecto‐ATPase by pyridoxal phosphate‐related compounds

K. Jacobson, C. Hoffmann, Yong‐Chul Kim, 2000, Drug development research.

Benserazide, the first allosteric inhibitor of Coxsackievirus B3 3C protease☆

Jia Jia Lim, S. Eom, Yong‐Chul Kim, 2015, FEBS Letters.

2,3,4-Trihydroxybenzyl-hydrazide analogues as novel potent coxsackievirus B3 3C protease inhibitors.

Yong‐Chul Kim, L. Jeong, E. Jeon, 2016, European journal of medicinal chemistry.

Structure−Activity Relationship Studies of Spinorphin as a Potent and Selective Human P2X3 Receptor Antagonist

Yong‐Chul Kim, Chul-Seung Park, Hyun-Ho Lim, 2007 .

Structure-activity relationship studies of spinorphin as a potent and selective human P2X(3) receptor antagonist.

Yong‐Chul Kim, Chul-Seung Park, Hyun-Ho Lim, 2007, Journal of medicinal chemistry.

Myeloid-Derived Suppressor Cells Are Controlled by Regulatory T Cells via TGF-β during Murine Colitis.

Jung Hyun Han, S. Mazmanian, Yong‐Chul Kim, 2016, Cell reports.

Myeloid-Derived Suppress or Cells Are Controlled by Regulatory T Cells via TGF-b during Murine Colitis Graphical

Jung Hyun Han, S. Mazmanian, Yong‐Chul Kim, 2022 .

Pyrazolodiazepine derivatives with agonist activity toward Drosophila RYamide receptor.

Young-Joon Kim, Yong‐Chul Kim, J. Kwon, 2016, Bioorganic & medicinal chemistry letters.

Discovery and structure-activity relationship studies of quinolinone derivatives as potent IL-2 suppressive agents.

Yong‐Chul Kim, Jin-Hee Park, Minjeong Kim, 2016, Bioorganic & medicinal chemistry.

Synthesis of pyridoxal phosphate derivatives with antagonist activity at the P2Y13 receptor.

K. Jacobson, Yong‐Chul Kim, J. Boeynaems, 2005, Biochemical pharmacology.

Indirubin derivatives as potent FLT3 inhibitors with anti-proliferative activity of acute myeloid leukemic cells.

Myoung Ju Moon, Soo-Jeong Choi, Yong‐Chul Kim, 2010, Bioorganic & medicinal chemistry letters.

Development of anti-coxsackievirus agents targeting 3C protease.

Yong‐Chul Kim, E. Jeon, Won-Gil Lee, 2012, Bioorganic & medicinal chemistry letters.

Activity of novel adenine nucleotide derivatives as agonists and antagonists at recombinant rat P2X receptors

G. Burnstock, K. Jacobson, Yong‐Chul Kim, 2000, Drug development research.

Structure-activity relationships of pyridoxal phosphate derivatives as potent and selective antagonists of P2X1 receptors.

G. Burnstock, K. Jacobson, G. Dubyak, 2001, Journal of medicinal chemistry.

Discovery of pyrazole-1-carboxamide derivatives as novel Gi-biased μ-opioid receptor agonists.

Sunhong Kim, Yong‐Chul Kim, M. Yoon, 2022, Drug development research.

Synthesis and structure-activity relationships of quinolinone and quinoline-based P2X7 receptor antagonists and their anti-sphere formation activities in glioblastoma cells.

W. Goddard, Ji‐Hyun Lee, C. Müller, 2018, European journal of medicinal chemistry.

Nanoparticle-encapsulated P2X₇ receptor antagonist in a pH-sensitive polymer as a potential local drug delivery system to acidic inflammatory environments.

Sun‐mi Lee, Yong‐Chul Kim, So-Deok Lee, 2015, Bioorganic & medicinal chemistry letters.

Structure-activity relationships and optimization of 3,5-dichloropyridine derivatives as novel P2X(7) receptor antagonists.

K. Kang, Yong‐Chul Kim, Won-Gil Lee, 2012, Journal of medicinal chemistry.

Structure–activity relationships of heteroaromatic esters as human rhinovirus 3C protease inhibitors

Soo-Jeong Choi, Yong‐Chul Kim, Ju-Yeon Lee, 2009, Bioorganic & Medicinal Chemistry Letters.

Discovery of a FLT3 inhibitor LDD1937 as an anti-leukemic agent for acute myeloid leukemia

Jungil Choi, Hyo-Jeong Lee, Yong‐Chul Kim, 2017, Oncotarget.

Crystallization and Preliminary X-Ray Crystallographic Studies of Rattus norvegicus Visfatin/PBEF/Nampt in Complex with an FK866-Based Inhibitor

S. Eom, Yongseong Kim, Jang-Soo Chun, 2009 .

Indirubin-3-monoxime Prevents Tumorigenesis in Breast Cancer through Inhibition of JNK1 Activity

Yong‐Chul Kim, Hee-Sae Park, E. Jo, 2021, Biomedical Science Letters.

Synthesis and Structure-activity Relationship Studies of 1,5-Isomers of Triazole-pyrrolopyrimidine as Selective Janus Kinase 1 (JAK1) Inhibitors.

Sun‐mi Lee, Yong‐Chul Kim, Woo‐Seok Kim, 2021, Bioorganic & medicinal chemistry letters.

Combinatorial synthesis and biological evaluation of peptide-binding GPCR-targeted library.

Yong‐Chul Kim, T. Webb, Ju Yeon Lee, 2009, Bioorganic chemistry.

Entry inhibition of hepatitis B virus using cyclosporin O derivatives with peptoid side chain incorporation.

Yong‐Chul Kim, Jiwon Seo, Yuri Cho, 2022, Bioorganic & medicinal chemistry.

Synthesis and structure‐activity relationships of pyridoxal‐6‐arylazo‐5′‐phosphate and phosphonate derivatives as P2 receptor antagonists

G. Burnstock, K. Jacobson, T. K. Harden, 1998, Drug development research.

Discovery of Novel Pyrimidine-Based Capsid Assembly Modulators as Potent Anti-HBV Agents.

Yong‐Chul Kim, Y. Kim, Yuri Cho, 2021, Journal of medicinal chemistry.

AI-based prediction of new binding site and virtual screening for the discovery of novel P2X3 receptor antagonists.

Hojung Nam, Yong‐Chul Kim, Ingoo Lee, 2022, European journal of medicinal chemistry.

Dynamin 2 Inhibitors as Novel Therapeutic Agents Against Cervical Cancer Cells.

Jeong-Won Lee, Y. Lee, Tae-Joong Kim, 2016, Anticancer research.

Synthesis of benzo[3,4]azepino[1,2-b]isoquinolin-9-ones from 3-arylisoquinolines via ring closing metathesis and evaluation of topoisomerase I inhibitory activity, cytotoxicity and docking study.

Kyung-Tae Lee, Yong‐Chul Kim, Ik-Soo Lee, 2011, Bioorganic & medicinal chemistry.

Stereoselective synthesis and osteogenic activity of subglutinols A and B.

Yong‐Chul Kim, Jiyong Hong, Dong-Sup Lee, 2009, Journal of the American Chemical Society.

Combinatorial Library Synthesis and Biological Evaluation of Pyrazolo[4,3‐e][1,4]diazepine as a Potential Privileged Structure

Ju-Yeon Lee, Yong‐Chul Kim, Ju-Yeon Lee, 2009, ChemMedChem.

5,5'-substituted indirubin-3'-oxime derivatives as potent cyclin-dependent kinase inhibitors with anticancer activity.

Sang Kook Lee, Soo-Jeong Choi, Yong‐Chul Kim, 2010, Journal of medicinal chemistry.

Synthesis and structure-activity relationships of novel, substituted 5,6-dihydrodibenzo[a,g]quinolizinium P2X7 antagonists.

Yong‐Chul Kim, ho-sung Lee, Won-Ki Kim, 2009, Bioorganic & medicinal chemistry letters.

Structure-activity relationships of thiazole and thiadiazole derivatives as potent and selective human adenosine A3 receptor antagonists.

K. Jacobson, Zhang-Guo Gao, Yong‐Chul Kim, 2004, Bioorganic & medicinal chemistry.

Design and synthesis of 1,4-dihydropyridine derivatives as BACE-1 inhibitors.

Soo-Jeong Choi, Yong‐Chul Kim, E. Jeon, 2010, European journal of medicinal chemistry.

Application of a novel design paradigm to generate general nonpeptide combinatorial scaffolds mimicking beta turns: synthesis of ligands for somatostatin receptors.

Yong‐Chul Kim, T. Webb, Dona Chianelli, 2003, Bioorganic & medicinal chemistry.

Solid-phase synthesis of tetrahydro-1,4-benzodiazepine-2-one derivatives as a beta-turn peptidomimetic library.

Young-Dae Gong, Isak Im, Yong‐Chul Kim, 2004, Journal of combinatorial chemistry.

N6-substituted D-4'-thioadenosine-5'-methyluronamides: potent and selective agonists at the human A3 adenosine receptor.

K. Jacobson, Zhang-Guo Gao, H. Moon, 2003, Journal of medicinal chemistry.

Escape from adamantane: Scaffold optimization of novel P2X7 antagonists featuring complex polycycles.

S. Vázquez, Yong‐Chul Kim, Lin-Hua Jiang, 2017, Bioorganic & medicinal chemistry letters.

Synthesis of potent chemical inhibitors of dynamin GTPase.

Yong‐Chul Kim, Sunghoe Chang, K. Jung, 2010, Bioorganic & medicinal chemistry letters.

Stimulation of the P2X7 receptor kills rat retinal ganglion cells in vivo.

K. Jacobson, A. Laties, Yong‐Chul Kim, 2008, Experimental eye research.

Interplay among Conformation, Intramolecular Hydrogen Bonds, and Chameleonicity in the Membrane Permeability and Cyclophilin A Binding of Macrocyclic Peptide Cyclosporin O Derivatives.

Chin-Ju Park, Yong‐Chul Kim, Jiwon Seo, 2021, Journal of medicinal chemistry.

Design, synthesis and anticancer activity of fluorocyclopentenyl-purines and - pyrimidines.

Yong‐Chul Kim, J. Lee, L. Jeong, 2018, European journal of medicinal chemistry.

Induction of apoptosis by a novel indirubin-5-nitro-3'-monoxime, a CDK inhibitor, in human lung cancer cells.

Myoung Ju Moon, Jong-Won Lee, Yong‐Chul Kim, 2005, Bioorganic & medicinal chemistry letters.

5‐diphenylacetamido‐indirubin‐3′‐oxime as a novel mitochondria‐targeting agent with anti‐leukemic activities

Yong‐Chul Kim, J. Song, Hyeoung-Joon Kim, 2016, Molecular carcinogenesis.

Eltrombopag as an Allosteric Inhibitor of the METTL3-14 Complex Affecting the m6A Methylation of RNA in Acute Myeloid Leukemia Cells

Yong‐Chul Kim, M. Jin, Hai-hong Shen, 2022, Pharmaceuticals.

Indirubin-3'-monoxime, a derivative of a Chinese anti-leukemia medicine, inhibits Notch1 signaling.

Yong‐Chul Kim, Mi-Yeon Kim, Jung-Soon Mo, 2008, Cancer letters.

Indirubin-3 0-monoxime , a derivative of a Chinese anti-leukemia medicine , inhibits Notch 1 signaling

Yong‐Chul Kim, Mi-Yeon Kim, Jung-Soon Mo, 2008 .

A novel indirubin derivative that increases somatic cell plasticity and inhibits tumorigenicity.

Darren R. Williams, Jeong-min Lee, Yong‐Chul Kim, 2019, Bioorganic & medicinal chemistry.

Potent Suppressive Effects of 1-Piperidinylimidazole Based Novel P2X7 Receptor Antagonists on Cancer Cell Migration and Invasion.

Darren R. Williams, C. Müller, Jeong-min Lee, 2016, Journal of medicinal chemistry.

Involvement of the P2X7 receptor in the migration and metastasis of tamoxifen-resistant breast cancer: effects on small extracellular vesicles production

K. Kang, N. Phuong, Sung-Chul Lim, 2019, Scientific Reports.

A3 adenosine receptors: Protective vs. damaging effects identified using novel agonists and antagonists

S. Moro, K. Jacobson, Yong‐Chul Kim, 1998, Drug development research.

The discovery of 2,5-isomers of triazole-pyrrolopyrimidine as selective Janus kinase 2 (JAK2) inhibitors versus JAK1 and JAK3.

Jiwon Kim, Sun Choi, K. Kang, 2016, Bioorganic & medicinal chemistry.

Development of Dibenzothiazepine Derivatives as Multifunctional Compounds for Neuropathic Pain

Ki Duk Park, Yong‐Chul Kim, Jong-Hyun Park, 2022, Pharmaceuticals.

Synthesis and structure-activity relationships of carboxylic acid derivatives of pyridoxal as P2X receptor antagonists.

Yong‐Chul Kim, K. Jung, Hyo Jun Kim, 2013, Bioorganic & medicinal chemistry.

FcγRIIb mediates amyloid-β neurotoxicity and memory impairment in Alzheimer's disease.

Junying Yuan, W. Klein, Sukwoo Choi, 2013, The Journal of clinical investigation.

Synthesis and Structure–Activity Relationship Studies of Benzimidazole-4,7-dione-Based P2X3 Receptor Antagonists as Novel Anti-Nociceptive Agents

Yong‐Chul Kim, W. Kim, M. Yoon, 2022, Molecules.

Ciclopirox inhibits Hepatitis B Virus secretion by blocking capsid assembly

Yong‐Chul Kim, Yuri Cho, Sung-Gyoo Park, 2019, Nature Communications.

Immunosuppressive Effects of Subglutinol Derivatives

Yong‐Chul Kim, Jiyong Hong, Hyoungsu Kim, 2012, ChemMedChem.

Pharmacological characterization of novel A3 adenosine receptor-selective antagonists

K. Jacobson, G. Stiles, Yong‐Chul Kim, 1997, Neuropharmacology.

Towards a Novel Class of Multitarget-Directed Ligands: Dual P2X7–NMDA Receptor Antagonists

Yong‐Chul Kim, S. Vázquez, F. Sureda, 2018, Molecules.

Discovery and Binding Mechanism of Pyrazoloisoquinoline-Based Novel β-Arrestin Inverse Agonists of the Kappa-Opioid Receptor.

W. Goddard, M. Yang, Sunhong Kim, 2023, Journal of medicinal chemistry.

Localization of a Site of Action for Benzofuroindole-Induced Potentiation of BKCa Channels

S. Eom, Keun Woo Lee, Yuno Lee, 2012, Molecular Pharmacology.

Discovery of Novel Biased Opioid Receptor Ligands through Structure‐Based Pharmacophore Virtual Screening and Experiment

Ki Duk Park, W. Goddard, Yong‐Chul Kim, 2019, ChemMedChem.

Solid-phase synthesis of quinolinone library.

Yong‐Chul Kim, H. Ko, Min Kim, 2015, ACS combinatorial science.

P2X7 receptor antagonists: a patent review (2010–2015)

Yong‐Chul Kim, Jin-Hee Park, 2017, Expert opinion on therapeutic patents.

Design and synthesis of anticonvulsive agents as γ-vinyl GABA-based potential dual acting prodrugs and their biological activities

Yong‐Chul Kim, Y. Jahng, Eun-kyung Kim, 2000 .

Characterization of the aminopyridine derivative KRC-180 as a JAK2 inhibitor

Sun‐mi Lee, Hyo-Jeong Lee, Yong‐Chul Kim, 2017, Oncology letters.

Design, synthesis and X-ray crystallographic study of NAmPRTase inhibitors as anti-cancer agents.

S. Eom, Yong‐Chul Kim, H. Youn, 2011, European journal of medicinal chemistry.

Natural product derivative BIO promotes recovery after myocardial infarction via unique modulation of the cardiac microenvironment

Min Chul Kim, W. S. Kang, Darren R. Williams, 2016, Scientific Reports.

Pheophorbide-a conjugates with cancer-targeting moieties for targeted photodynamic cancer therapy.

Yong‐Chul Kim, J. Yoon, H. Yoon, 2015, Bioorganic & medicinal chemistry.

Synthesis of pheophorbide-a conjugates with anticancer drugs as potential cancer diagnostic and therapeutic agents.

Yong‐Chul Kim, J. Yoon, H. Yoon, 2011, Bioorganic & medicinal chemistry.

Anti-tumor activity of noble indirubin derivatives in human solid tumor models In Vitro

Soo-Jeong Choi, Yong‐Chul Kim, H. Kuh, 2009, Archives of pharmacal research.

Discovery of an Indirubin Derivative as a Novel c-Met Kinase Inhibitor with In Vitro Anti-Tumor Effects

Hyo-Jeong Lee, Yong‐Chul Kim, Sun-Young Han, 2018, Biomolecules & therapeutics.

Discovery of novel 2,5-dioxoimidazolidine-based P2X(7) receptor antagonists as constrained analogues of KN62.

K. Kang, Sung-Chul Lim, Yong‐Chul Kim, 2015, Journal of medicinal chemistry.

Synthesis and structure-activity relationships of pyrazolodiazepine derivatives as human P2X7 receptor antagonists.

Yong‐Chul Kim, Ju-Yeon Lee, Juan Yu, 2009, Bioorganic & medicinal chemistry letters.

Synthesis and structure-activity relationship studies of tyrosine-based antagonists at the human P2X7 receptor.

K. Jacobson, H. Moon, Yong‐Chul Kim, 2008, Bioorganic & medicinal chemistry letters.

Structure-activity relationship studies of pyrimidine-2,4-dione derivatives as potent P2X7 receptor antagonists.

Yong‐Chul Kim, Jin-Hee Park, H. Ko, 2015, European journal of medicinal chemistry.

Acyclic Analogues of Deoxyadenosine 3′,5′‐Bisphosphates as P2Y1 Receptor Antagonists.

K. Jacobson, Yong‐Chul Kim, J. Boyer, 2000 .

Ciclopirox inhibits Hepatitis B Virus secretion by blocking capsid assembly

Yong‐Chul Kim, Yuri Cho, Sung-Gyoo Park, 2019, Nature Communications.

Kinetic profiling and functional characterization of 8-phenylxanthine derivatives as A2B adenosine receptor antagonists

K. Jacobson, A. IJzerman, H. de Vries, 2022, Biochemical pharmacology.

Discovery of antiviral SARS-CoV-2 main protease inhibitors by structure-guided hit-to-lead optimization of carmofur

Yong‐Chul Kim, M. Jin, Y. Jang, 2023, European Journal of Medicinal Chemistry.

Discovery and structure-activity relationships of pyrazolodiazepine derivatives as the first small molecule agonists of the Drosophila sex peptide receptor.

Yong‐Chul Kim, Ju-Yeon Lee, Young-Joon Kim, 2015, Bioorganic & Medicinal Chemistry.

Structure-based virtual screening and biological evaluation of potent and selective ADAM12 inhibitors.

Young Hoon Kim, Woo Jin Park, Jeong Hyeok Yoon, 2004, Bioorganic & medicinal chemistry letters.

P2X7 receptor antagonists: a patent review (2010–2015)

Yong‐Chul Kim, Jin-Hee Park, 2017, Expert opinion on therapeutic patents.

The discovery of 2,5-isomers of triazole-pyrrolopyrimidine as selective Janus kinase 2 (JAK2) inhibitors versus JAK1 and JAK3.

Jiwon Kim, Sun Choi, K. Kang, 2016, Bioorganic & medicinal chemistry.

Discovery of 5-methyl-1H-benzo[d]imidazole derivatives as novel P2X3 Receptor Antagonists.

Yong‐Chul Kim, Jinsu Bae, Koon Mook Kang, 2022, Bioorganic & medicinal chemistry letters.

Novel inhibitors of lysine (K)-specific Demethylase 4A with anticancer activity

Hyo-Jeong Lee, Yong‐Chul Kim, Sun-Young Han, 2017, Investigational New Drugs.

Derivatives of the triazoloquinazoline adenosine antagonist (CGS 15943) having high potency at the human A2B and A3 receptor subtypes.

S. Moro, K. Jacobson, A. IJzerman, 1998, Journal of medicinal chemistry.

Structure-activity relationships of bisphosphate nucleotide derivatives as P2Y1 receptor antagonists and partial agonists.

K. Jacobson, P. Herdewijn, T. K. Harden, 1999, Journal of medicinal chemistry.

Novel small molecule activators of beta-catenin-mediated signaling pathway: structure-activity relationships of indirubins.

Soo-Jeong Choi, Yong‐Chul Kim, E. Park, 2009, Bioorganic & medicinal chemistry letters.

A pyridoxine cyclic phosphate and its 6-azoaryl derivative selectively potentiate and antagonize activation of P2X1 receptors.

G. Burnstock, K. Jacobson, Yong‐Chul Kim, 1998, Journal of medicinal chemistry.

5‐Nitro‐5′hydroxy‐indirubin‐3′oxime Is a Novel Inducer of Somatic Cell Transdifferentiation

Yong‐Chul Kim, Young-Jin Hong, Hai-hong Shen, 2014, Archiv der Pharmazie.